NCT05997550Completed
The Effect of Pursed Lip Breathing Exercise and Laughter Therapy Individuals With The COPD
The Effect of Pursed Lip Breathing Exercise and Laughter Therapy on Dyspnea, Health Status, and Care Dependence in Individuals With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 3 Feb 2026
Brief summary (registry, in English)
Chronic Obstructive Pulmonary Disease is a chronic disease with increasing mortality, morbidity and prevalence in the world and in our country, and in which serious symptoms, especially dyspnea, develop. Due to dyspnea and symptoms, patients experience deterioration in their health status and an increase in care dependency. This research is a single-blind, randomized controlled experimental study designed to determine the effects of pursed lip breathing exercise and laughter therapy on dyspnea severity, health status and care dependence in individuals with COPD. The research will be carried out with a total of 63 patients in Ankara City Hospital Chest Diseases unit. The patients will be stratified according to smoking status and COPD Assessment Test scores with the randomization program and assigned to 2 intervention groups and 1 control group. During the first interview, patients in the 1st intervention group will be provided with pursed lip breathing exercise training and application, and training videos and brochures will be given. 2. The patients in the intervention group will be given laughter therapy training and practice, and an educational brochure will be given. The patients in the control group will also receive face-to-face training on lung structure and functioning, and a brochure will be given. Patients in the laughter therapy and pursed lip breathing exercise intervention groups will be asked to perform these practices three days a week (Monday, Wednesday, Friday) for 8 weeks. At the beginning of the study, at the 4th, 8th, and 12th weeks, the Dyspnea 12-TR Scale, the COPD Evaluation Test, and the Care Dependency Scale will be administered to both the intervention and control group patients. In the application of the scales and the analysis of the data, the groups will be blinded, and the scale application will be made by an independent interviewer. After the analysis of the data in terms of normal distribution was done with the Kolmogorow Smirnov test, in the comparison of the data of the patients in the intervention and control groups; One Way Analysis of Variance or Kruskal-Wallis Analysis of Variance will be applied. Analysis of Variance in Repeated Measurements or Freidman's test will be used to calculate the change in groups over time. The statistical significance limit will be accepted as p\<0.05.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 63 (actual)
- First submitted
- 16 Jun 2023
- Start date
- 15 Aug 2022
- Primary completion date
- 15 Aug 2024
- Lead sponsor
- Yuksek Ihtisas University
- Diseases
- COPD
- NCT number
- NCT05997550
What you commit to
- Study type: Interventional
- Participants enrolled: 63
- From 15 Aug 2022 to the primary completion date, 15 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not complying with pursed lip breathing exercise and laughter therapy and program,
- Changes in bronchodilator and oxygen therapy regimens,
Other illness
- Developing a disease that may affect the health status or a condition requiring hospitalization (COPD exacerbation, etc.) during the 12-week period during which the research will take place,
- A situation that is not suitable for laughter therapy due to the diagnosis of surgery in the abdominal region, uncontrollable hypertension, glaucoma, abdominal hernia, epilepsy,
Other
- Patients who want to withdraw from the study are excluded from the study.
Who the study is looking for
- Those aged 40 and over,
- He was diagnosed with COPD as a result of medical history, physical examination and pulmonary function tests, and his CAT score is 10 and above according to the COPD Unified Assessment\* of the GOLD guide; In Group B and D (1),
- There is no diagnosis of a disease that may affect the cognitive state,
- Not having a diagnosis of a physical or mental illness that will prevent communication, and able to use a telephone.
- Individuals who agree to participate in the research are included in the study
- Non-Inclusion Criteria:
- Those who have difficulty in verbal communication (intubation, tracheostomy, delirium, etc.)
- With a CAT score of less than 10 and in Groups A and C according to the COPD Combined Assessment\* of the GOLD guide,
- Having a disorder that disrupts the cognitive process such as schizophrenia or dementia
- Alcohol, substance addiction,
- Laughter therapy was not deemed appropriate due to the diagnosis of abdominal surgery, uncontrolled hypertension, glaucoma, abdominal hernia, epilepsy in the last three months,
- Using complementary and integrative treatments such as acupuncture, meditation, yoga, massage, relaxation exercises,
- Patients who do not agree to participate in the study are excluded from the study.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bilkent City Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.